Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZNF672 Inhibitors

Zinc finger protein 672 (ZNF672) inhibitors encompass a range of chemical compounds that directly or indirectly suppress the functional activity of ZNF672 by targeting the DNA-binding capacity or the transcription regulation pathways it influences. Compounds like Quinomycin A and Mithramycin A intercalate into DNA or bind to specific DNA regions, respectively, preventing ZNF672 from interacting with its target DNA sequences and thereby reducing its ability to regulate gene expression. Similarly, Chloroquine disrupts DNA function by intercalating, which could prevent the ZNF672 protein from effectively binding to DNA. Cisplatin forms crosslinks within DNA strands, which could obstruct the interaction of ZNF672 with its DNA recognition sites, leading to diminished transcriptional activity. Furthermore, Trichostatin A and Psammaplin A, as histone deacetylase inhibitors, modify chromatin structure, potentially restricting ZNF672's access to DNA and its recruitment of co-repressors, decreasing its gene silencing capacity.

Additional chemicals like 5-Azacytidine and 5-Aza-2′-Deoxycytidine serve as DNA methyltransferase inhibitors, altering the epigenetic landscape and potentially disrupting the regulatory patterns that ZNF672 controls. RG 108, another inhibitor in this category, could similarly diminish the impact of ZNF672 on gene expression by preventing DNA methylation. Distamycin A targets AT-rich regions of DNA where ZNF672 may bind, further impeding the protein's involvement in gene regulation. Collectively, these inhibitors employ various strategies to interfere with the DNA binding and transcriptional regulation exerted by ZNF672, culminating in a comprehensive diminution of its biological activity without affecting its expression levels directly.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Quinomycin A

512-64-1sc-202306
1 mg
$166.00
4
(1)

Inhibits the DNA binding activity of transcription factors. Quinomycin A binds to the minor groove of DNA, thereby preventing ZNF672 from interacting with its target DNA sequences, leading to a decrease in its transcription regulatory activity.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Intercalates into DNA, potentially disrupting DNA-related functions. Chloroquine's intercalation may impair ZNF672's ability to bind DNA effectively, diminishing its regulatory role in gene expression.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A cytidine analog that incorporates into DNA and RNA and inhibits DNA methyltransferases. This results in the hypomethylation of DNA, which might alter the gene expression patterns that ZNF672 regulates, indirectly diminishing its functional impact on transcriptional regulation.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

A histone deacetylase inhibitor that leads to increased acetylation of histones, changing the chromatin structure to a more open state. This alteration can inhibit ZNF672 from accessing DNA or from recruiting co-repressors, thereby diminishing its role in gene silencing.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$138.00
$380.00
101
(4)

Forms DNA adducts and crosslinks within and between DNA strands. These crosslinks could hinder ZNF672 from binding to its target DNA sites, therefore reducing its transcriptional regulatory functions.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Binds to G-C rich regions of DNA, inhibiting transcription factors from binding. It would limit ZNF672's ability to bind to its DNA recognition sequences, thus diminishing its transcriptional regulatory activity.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

A non-nucleoside DNA methyltransferase inhibitor that prevents DNA methylation. By altering the methylation status of genes regulated by ZNF672, RG 108 could indirectly reduce the functional influence of ZNF672 on these genes.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

A nucleoside analog that inhibits DNA methyltransferase, leading to DNA demethylation. It could disrupt the transcriptional repression potentially mediated by ZNF672 through changes in DNA methylation patterns.

Psammaplin A

110659-91-1sc-258049
sc-258049A
1 mg
5 mg
$90.00
$422.00
7
(1)

Inhibits DNA methyltransferases and histone deacetylases. By altering epigenetic marks, it may affect the transcriptional regulation by ZNF672, diminishing its role in gene expression.